Reporting owner · CIK 0001786720
Saxonov Serge
Visual SEC Form 4 history across 1 companies, 12 transactions and 7 filings.
CEOChief Executive Officer10x Genomics, Inc.
Open-market mix
0%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Feb 25
−$140.7K
Mar 25
$0
Jan 26
$0
May 26
−$709.1K
Aug 26
−$1.2M
Sep 26
$0
Transaction texture
Ownership and ticket size
Average P/S size$403.7K
Median P/S size$264.8K
Direct12
Indirect0
Sep 01, 2026gift
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest buy
No open-market insider purchase is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| TXG | Saxonov Serge | CEO | sale10b5-1 | 7.94k | -$8.43M | S | — | 03/04/2025 | 02/28/2025 | |
| TXG | Saxonov Serge | CEO | sale | 5.09k | -$5.63M | S | — | 02/26/2025 | 02/24/2025 |
Saxonov Serge Insider Activity FAQ
SEC Form 4 context
Who is Saxonov Serge?
Saxonov Serge is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001786720.
Which companies has Saxonov Serge reported transactions for?
10x Genomics, Inc.
When was Saxonov Serge's latest insider buy?
No open-market insider purchase is available for this period.
When was Saxonov Serge's latest insider sale?
sale at 10x Genomics, Inc. on Aug 24, 2026 valued at $1,168,775.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.